360 GENOMICS LIMITED

Dissolved Penarth

Research and experimental development on biotechnology

0 employees website.com
Research and experimental development on biotechnology
3

360 GENOMICS LIMITED

Research and experimental development on biotechnology

Founded 23 Jul 2007 Dissolved Penarth, Wales 0 employees website.com
Research and experimental development on biotechnology

Previous Company Names

360 DIAGNOSTICS LIMITED 23 Jul 2007 — 19 Feb 2009
Accounts Submitted 26 Jun 2023
Confirmation
Net assets £0 £154K 2022 year on year
Total assets £0
Total Liabilities £0 £154K 2022 year on year
Charges None No charges registered

Contact & Details

Contact

Registered Address

Avon House 19 Stanwell Road Penarth South Glamorgan CF64 2EZ Wales

Telephone

0800 000 0000

Email

info@example.com

Website

www.example.com

Full company profile for 360 GENOMICS LIMITED (06321451), a dissolved company based in Penarth, Wales. Incorporated 23 Jul 2007. Research and experimental development on biotechnology. View financials, directors, shareholders, and filings.

Business Summary

This company specializes in providing innovative solutions and services across multiple sectors.

Products & Services

consulting software analytics integration

Reports

Credit Report

In-depth credit score, financial analysis, risk assessment and company intelligence.

Financials

Financials

Period 1 Jan → 31 Dec 2022
Type Total Exemption Full
Next accounts 31 December 2023
Due by 30 September 2024 9 months

Balance Sheet & P&L (2013–2022)

Cash in Bank

N/A

Net Assets

N/A

Increased by £154.48k (+100%)

Total Liabilities

N/A

Decreased by £154.48k (-100%)

Turnover

N/A

Employees

N/A

Debt Ratio

N/A

Financial History

Revenue, profit, EBITDA and key financial figures

2022
Dec Year End
2021
Dec Year End
P&L
Revenue
£142.3M
£128.7M
Gross Profit
£48.2M
£43.1M
Operating Profit
£22.4M
£19.8M
Net Profit
£18.1M
£15.9M
EBITDA
£31.5M
£28.2M
Assets
Cash
£24.7M
£21.3M
Total Assets
£89.4M
£82.1M
Liabilities
Total Liabilities
£45.2M
£41.8M
Key Metrics
Employees
1,247
1,156
Latest Revenue
£142.3M
Latest EBITDA
£31.5M
Cash Position
£24.7M

Funding

Fundraising & Grants

No fundraising or grants recorded

Investors (0)

No investor information available

Officers

Officers

1 active 2 resigned
Status
David Michael SalterDirectorBritishUnited States641 Jan 2022Active

Shareholders

Shareholders (1)

Ekf Molecular Diagnostics Limited
100.0%
10,568

Persons with Significant Control

Persons with Significant Control (1)

1 Active
Active
Notified 3 Jun 2016
Nature of Control
  • Ownership Of Shares 75 To 100 Percent

Group Structure

Group Structure

360 GENOMICS LIMITED Current Company

Charges

Charges

No charges registered

Properties

Properties

0 total

No related properties

Documents

Company Filings

DateCategoryDescriptionDocument
19 Sept 2023GazetteGazette Dissolved Voluntary
4 Jul 2023GazetteGazette Notice Voluntary
27 Jun 2023DissolutionDissolution Application Strike Off Company
26 Jun 2023OtherNotice of agreement to exemption from audit of accounts for period ending 31/12/22
26 Jun 2023AccountsAnnual accounts made up to 2022-12-31
19 Sept 2023 Gazette

Gazette Dissolved Voluntary

4 Jul 2023 Gazette

Gazette Notice Voluntary

27 Jun 2023 Dissolution

Dissolution Application Strike Off Company

26 Jun 2023 Other

Notice of agreement to exemption from audit of accounts for period ending 31/12/22

26 Jun 2023 Accounts

Annual accounts made up to 2022-12-31

Recent Activity

Latest Activity

Gazette Dissolved Voluntary

2 years ago on 19 Sept 2023

Gazette Notice Voluntary

2 years ago on 4 Jul 2023

Dissolution Application Strike Off Company

2 years ago on 27 Jun 2023

Notice of agreement to exemption from audit of accounts for period ending 31/12/22

2 years ago on 26 Jun 2023

Annual accounts made up to 2022-12-31

2 years ago on 26 Jun 2023